Safety and efficacy of once-weekly carfilzomib (K) dosing in frail patients (pts): a subgroup analysis from the phase 3 A.R.R.O.W. study
Mateos, Maria-Victoria, Ludwig, Heinz, Kumar, Shaji, Rosenbaum, Cara, Huang, Mei, Goldrick, Amanda, Blaedel, Julie, Dimopoulos, Meletios A.Volume:
19
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2019.09.047
Date:
October, 2019
File:
PDF, 88 KB
2019